Last Updated: June 17, 2026

Profiles for companies starting with 'g'


✉ Email this page to a colleague

« Back to Dashboard


Drugs and US Patents for g

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare REGADENOSON regadenoson SOLUTION;INTRAVENOUS 215955-001 Aug 5, 2024 DISCN No No ⤷  Start Trial ⤷  Start Trial
Granules DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 215771-007 Dec 28, 2021 AB RX No No ⤷  Start Trial ⤷  Start Trial
Ge Healthcare GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 017700-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial
Genzyme Corp WAYRILZ rilzabrutinib TABLET;ORAL 219685-001 Aug 29, 2025 RX Yes Yes 11,708,370 ⤷  Start Trial Y ⤷  Start Trial
Ge Healthcare FLUORINE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 017042-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
Giskit EXEM FOAM KIT air polymer-type a FOAM;INTRAUTERINE 212279-001 Nov 7, 2019 RX Yes Yes 9,034,300 ⤷  Start Trial Y ⤷  Start Trial
Gland ZOLEDRONIC ACID zoledronic acid INJECTABLE;INTRAVENOUS 204217-001 Aug 18, 2016 AP RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.